Business Wire

Transition Industries Signs Heads of Agreement with Bonatti S.p.A for Critical Infrastructure on Pacifico Mexinol Project

14.8.2025 15:05:00 CEST | Business Wire | Press release

Share

Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and green hydrogen projects, signed a Heads of Agreement contract with Bonatti, an international contractor specializing in the energy sector, for critical infrastructure on the Pacifico Mexinol project in Sinaloa, Mexico.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814767897/en/

Pacifico Mexinol is poised to be the world’s largest standalone ultra-low carbon chemical production facility in the world, with an output of 6,130 metric tons of methanol (MT) per day.

Under the terms of the Heads of Agreement, which includes a lump sum binding price, Bonatti will be responsible for the detailed engineering, procurement, construction, pre-commissioning, commissioning, and startup for the upgrade of the port facilities and jetty at the Terminal Transoceánica de Topolobampo, S.A. de C.V. (“TTT”) port area where all methanol loading operations for export will occur. Bonatti will also be responsible for detailed engineering, procurement, construction, pre-commissioning, commissioning, and startup of the methanol transfer and vapor recovery underground pipelines and dual fiber optic cables between the Methanol main process plant and the Mexinol port site.

The agreement also provides Bonatti with the opportunity to build the project’s closed-loop water pipeline system from the JAPAMA oxidation pools to the site, making the Pacifico Mexinol site one of the world's largest applications of industrial water reuse from municipal effluent. This system treats and recycles municipal wastewater for all project needs in order to avoid tapping into freshwater sources or negatively impacting the Bay of Ohuira, thereby reducing the project’s environmental impact.

Balmore Brito, Pacifico Mexinol Project Director and Head of Engineering and Technology for Transition Industries said: “We are proud to have Bonatti, a world-leader in pipeline EPCs, as part of our execution team. Their international expertise coupled with their local field experience and knowledge operating in Ahome Municipality, Sinaloa, is good for the project and the local communities near where we operate. Bonatti shares our unwavering commitment to environmental and social sustainability.”

Gustavo Blejer, Bonatti’s Commercial Director for the Americas, said: “We are thrilled to be part of this flagship project, which marks an important step toward decarbonization. This is a great opportunity to combine Bonatti’s global expertise with our strong local experience, and to contribute meaningfully to the development of Ahome, Sinaloa, and Mexico.”

Transition Industries is jointly developing Pacifico Mexinol with the International Finance Corporation (IFC), a member of the World Bank Group. When it initiates operations in 2029, Pacifico Mexinol is expected to be the largest single ultra-low carbon methanol facility in the world – producing approximately 350,000 MT of green methanol and 1.8 million MT of blue methanol annually from natural gas with carbon capture.

ABOUT TRANSITION INDUSTRIES

Transition Industries LLC, based in Houston, Texas, is a developer of world-scale, net-zero carbon emissions methanol and green hydrogen projects in North America to address climate change and promote environmental and social sustainability. For additional information about Pacifico Mexinol or Transition Industries, email inquiries@transitionind.com.

ABOUT BONATTI

Bonatti is an international contractor with over 80 years of experience in the energy and mining sectors. The company’s expertise covers the full project lifecycle—from engineering, procurement, and construction to the operation and maintenance of plants and pipelines. Bonatti is actively engaged in the energy transition and water sustainability sectors. Ongoing projects include carbon capture, hydrogen, biofuel, and solar power plants, as well as water infrastructure developments designed to reduce freshwater use in mining operations. With operations spanning Canada, Mexico, and Chile, Bonatti has established a strong presence across the Americas. Having generated USD 2.5B+ in cumulative revenues, the company is recognized as Mexico’s leading midstream contractor. For more information, visit www.bonatti.it.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250814767897/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye